Organovo Holdings Files Q3 FY25 10-Q
Ticker: VIVS · Form: 10-Q · Filed: Feb 19, 2025 · CIK: 1497253
| Field | Detail |
|---|---|
| Company | Organovo Holdings, Inc. (VIVS) |
| Form Type | 10-Q |
| Filed Date | Feb 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotechnology, reporting
TL;DR
Organovo Holdings 10-Q filed: Q3 FY25 results in, check financials for R&D and Mosaic segments.
AI Summary
Organovo Holdings, Inc. filed its 10-Q for the period ending December 31, 2024. The filing covers the third quarter of their fiscal year 2025. Key financial details and operational segments, such as Research & Development and Mosaic, are presented for the periods ending December 31, 2024, and September 30, 2024, with comparative data from the previous fiscal year.
Why It Matters
This filing provides investors with an update on Organovo's financial performance and operational status for the third quarter of fiscal year 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — The company operates in the biotechnology sector, which is inherently high-risk due to research and development uncertainties and regulatory hurdles.
Key Numbers
- Q3 2025 — Fiscal Quarter (Reporting period for the 10-Q filing.)
- 2024-12-31 — Period End Date (The end date for the financial reporting period.)
- 2023-09-30 — Comparative Period End Date (Provides a point of comparison for financial performance.)
Key Players & Entities
- ORGANOVO HOLDINGS, INC. (company) — Filer
- 20241231 (date) — Period of Report
- 20250219 (date) — Filing Date
- SAN DIEGO, CA (location) — Business Address
- 001-35996 (company) — SEC File Number
- UniversityOfMissouriMember (company) — Mentioned entity
- ViscientBiosciencesMember (company) — Mentioned entity
FAQ
What were the key financial highlights for Organovo Holdings in the third quarter of fiscal year 2025?
The 10-Q filing for the period ending December 31, 2024, provides the financial details for Q3 FY25, but specific dollar amounts for revenue, net income, or loss are not detailed in the provided header information.
Which operational segments are highlighted in this 10-Q filing?
The filing mentions the 'ResearchDevelopmentSegmentMember' and 'MosaicSegmentMember' as key operational segments for Organovo Holdings.
What is the fiscal year end for Organovo Holdings?
Organovo Holdings' fiscal year ends on March 31, as indicated by the 'FISCAL YEAR END: 0331' information.
When was Organovo Holdings previously known by another name?
The company was formerly known as REAL ESTATE RESTORATION & RENTAL, INC., with a name change date of 20100722.
Are there any specific partnerships or collaborations mentioned in the filing header?
The header mentions 'UniversityOfMissouriMember' and 'ViscientBiosciencesMember' in relation to specific date ranges, suggesting potential past or ongoing collaborations or research activities.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on February 19, 2025 regarding ORGANOVO HOLDINGS, INC. (VIVS).